Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate

Journal of Medicinal Chemistry
1993.0

Abstract

Study of P2-purinoceptor subtypes has been difficult due to the lack of potent and selective ligands. With the goal of developing high affinity P2-purinoceptor-selective agonist, we have synthesized a series of analogues of adenine nucleotides modified on the purine ring as chain-extended 2-thioethers or as N6-methyl-substituted compounds. Chemical functionality incorporated in the thioether moiety included cyanoalkyl, nitroaromatic, amino, thiol, cycloalkyl, n-alkyl, and olefinic groups. Apparent affinity of the compounds for P2Y-purinoceptors was established by measurement of P2Y-purinoceptor-promoted phospholipase C activity in turkey erythrocyte membranes and relaxation of carbachol-contracted smooth muscle in three different preparations (guinea pig taenia coli, rabbit aorta, and rabbit mesenteric artery). Activity at P2X-purinoceptors was established by measurement of contraction of rabbit saphenous artery and of the guinea pig vas deferens and urinary bladder. All 11 of the 2-thioethers of ATP stimulated the production of inositol phosphates with K0.5 values of 1.5-770 nM, with an (aminophenyl)ethyl derivative being most potent. Two adenosine diphosphate analogues were equipotent to the corresponding ATP analogues. Adenosine monophosphate analogues were full agonists, although generally 4 orders of magnitude less potent. ATP 2-thioethers displayed pD2 values in the range of 6-8 in smooth muscle assay systems for activity at P2Y-receptors. There was a significant correlation for the 2-thioether compounds between the pK0.5 values for inositol phosphate production and the pD2 values for relaxation mediated via the P2Y-purinoceptors in the guinea pig taenia coli, but not for the vascular P2Y-receptors or for the P2X-receptors. At P2X-receptors, no activity was observed in the rabbit saphenous artery, but variable degrees of activity were observed in the guinea pig vas deferens and bladder depending on distal substituents of the thioether moiety. N6-Methyl-ATP was inactive at P2X-receptors, and approximately equipotent to ATP at taenia coil P2Y-receptors. This suggested that hybrid N6-methyl and 2-thioether ATP derivatives might be potent and selective for certain P2Y-receptors, as was shown for one such derivative, N6-methyl-2-(5-hexenylthio)-ATP.

Knowledge Graph

Similar Paper

Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate
Journal of Medicinal Chemistry 1993.0
2-Thioether 5‘-O-(1-Thiotriphosphate)adenosine Derivatives as New Insulin Secretagogues Acting through P2Y-Receptors
Journal of Medicinal Chemistry 1999.0
Structure−Activity Relationships of Bisphosphate Nucleotide Derivatives as P2Y<sub>1</sub> Receptor Antagonists and Partial Agonists
Journal of Medicinal Chemistry 1999.0
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists
Bioorganic &amp; Medicinal Chemistry 2008.0
Synthesis and Structure−Activity Relationships of Uracil Nucleotide Derivatives and Analogues as Agonists at Human P2Y<sub>2</sub>, P2Y<sub>4</sub>, and P2Y<sub>6</sub>Receptors
Journal of Medicinal Chemistry 2006.0
Synthesis and P2Y receptor activity of nucleoside 5′-phosphonate derivatives
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
Structural Modifications of UMP, UDP, and UTP Leading to Subtype-Selective Agonists for P2Y<sub>2</sub>, P2Y<sub>4</sub>, and P2Y<sub>6</sub> Receptors
Journal of Medicinal Chemistry 2011.0
Adenine Nucleotide Analogues Locked in a Northern Methanocarba Conformation:  Enhanced Stability and Potency as P2Y<sub>1</sub> Receptor Agonists
Journal of Medicinal Chemistry 2002.0
Novel nucleotide triphosphates as potent P2Y2 agonists
Bioorganic &amp; Medicinal Chemistry Letters 2007.0
Deoxyadenosine Bisphosphate Derivatives as Potent Antagonists at P2Y<sub>1</sub> Receptors
Journal of Medicinal Chemistry 1998.0